{"disease":{"id":"lung-metastatic-nasopharyngeal-carcinoma","name":"lung metastatic nasopharyngeal carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02834013","title":"Nivolumab and Ipilimumab in Treating Patients With Rare Tumors","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":818,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}